Nipro Corporation

8086.T
Medical Instruments & Supplies
2026/08/10 Updated
Market Cap: $1.7B (¥262.6B)
Stock Price: $10.19 (¥1,610)
Exchange Rate: 1 USD = ¥157.98

[Nipro] Q1 Consolidated Financial Results for the Period Ending March 2027|First Quarter

For the first quarter of the fiscal year ending March 2027, the consolidated results show net sales of 159,220 million yen, operating income of 7,212 million yen, ordinary income of 7,385 million yen, and net income attributable to owners of the parent of 7,385 million yen. Direct YoY comparison is not available.

Importance:
Page Updated: August 10, 2026
IR Disclosure Date: August 10, 2026

Key Figures

  • Net sales: 159,220 million yen
  • Operating income: 7,212 million yen
  • Ordinary income: 7,385 million yen

AI要約

Overview of Results

Consolidated net sales for this quarter were 159,220 million yen, with operating income of 7,212 million yen, ordinary income of 7,385 million yen, and net income attributable to owners of the parent of 7,385 million yen. The breakdown by segment is provided in the accompanying table. Overall, there may be combined effects from changes in raw material costs, labor costs, and general and administrative expenses, but the document does not provide a direct YoY figure.

Outlook and Notes

The document does not contain specific upward or downward revisions to the full-year outlook for the fiscal year ending March 2027, but quarterly results appear to be trending solidly. The attached materials to the financial results include the breakdown of assets and liabilities, cash flow status, and the segment-by-segment sales and profits, so investors should monitor future segment trends and cost structure changes.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Nipro Corporation

Company overview · Stock price · Financial data · All IR

View company page →